Document is current
Any future updates will be listed below
-
Authors
de Almeida, Melanie https://orcid.org/0000-0003-4871-2069
Hinterndorfer, Matthias https://orcid.org/0000-0003-2435-4690
Brunner, Hanna https://orcid.org/0000-0002-3446-3738
Grishkovskaya, Irina https://orcid.org/0000-0003-0164-9373
Singh, Kashish https://orcid.org/0000-0002-9891-8148
Schleiffer, Alexander https://orcid.org/0000-0001-6251-2747
Jude, Julian
Deswal, Sumit
Kalis, Robert https://orcid.org/0000-0001-7553-4806
Vunjak, Milica https://orcid.org/0000-0001-6330-363X
Lendl, Thomas https://orcid.org/0000-0003-4596-9512
Imre, Richard
Roitinger, Elisabeth https://orcid.org/0000-0002-3405-7801
Neumann, Tobias https://orcid.org/0000-0003-3908-4224
Kandolf, Susanne https://orcid.org/0000-0002-4007-6283
Schutzbier, Michael
Mechtler, Karl https://orcid.org/0000-0002-3392-9946
Versteeg, Gijs A. https://orcid.org/0000-0002-6150-2165
Haselbach, David https://orcid.org/0000-0002-5276-5633
Zuber, Johannes https://orcid.org/0000-0001-8810-6835
- License Information
-
More Information
Article History
Received: 25 March 2021
Accepted: 16 September 2021
First Online: 28 October 2021
Competing interests
: J.Z. is a founder, shareholder and scientific advisor of Quantro Therapeutics. J.Z., D.H. and the Zuber and Haselbach laboratories receive research support and funding from Boehringer Ingelheim. J.J. is now an employee of Twist Bioscience and T.N. is now an employee of Quantro Therapeutics. Other authors declare no competing interests.
